Central pontine myelinolysis natural history, complications and prognosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Central pontine myelinolysis}} | {{Central pontine myelinolysis}} | ||
{{CMG}}; {{AE}} {{MMJ}} | {{CMG}}; {{AE}} {{MMJ}} | ||
==Overview== | ==Overview== | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
===Natural History=== | ===Natural History=== | ||
*The symptoms of | *The symptoms of central pontine myelinolysis usually develop in the first/ second/ third decade of life and start with symptoms such as ___. | ||
*The symptoms of | *The symptoms of central pontine myelinolysis typically develop ___ years after exposure to ___. | ||
*If left untreated, [#]% of patients with | *If left untreated, [#]% of patients with central pontine myelinolysis may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3]. | ||
===Complications=== | ===Complications=== | ||
*Common complications of | *Common complications of central pontine myelinolysis include: | ||
**[Complication 1] | **[Complication 1] | ||
**[Complication 2] | **[Complication 2] | ||
Line 28: | Line 20: | ||
===Prognosis=== | ===Prognosis=== | ||
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with | *Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with central pontine myelinolysis is approximately [--]%. | ||
*Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent. | *Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent. | ||
*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with | *The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with central pontine myelinolysis. | ||
*[Subtype of disease/malignancy] is associated with the most favorable prognosis. | *[Subtype of disease/malignancy] is associated with the most favorable prognosis. | ||
*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis. | *The prognosis varies with the [characteristic] of the tumor; [subtype of disease/malignancy] have the most favorable prognosis. | ||
==References== | ==References== |
Revision as of 01:35, 11 September 2019
Central pontine myelinolysis Microchapters |
Differentiating Central pontine myelinolysis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Central pontine myelinolysis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Central pontine myelinolysis natural history, complications and prognosis |
FDA on Central pontine myelinolysis natural history, complications and prognosis |
CDC on Central pontine myelinolysis natural history, complications and prognosis |
Central pontine myelinolysis natural history, complications and prognosis in the news |
Blogs on Central pontine myelinolysis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Natural History, Complications, and Prognosis
Natural History
- The symptoms of central pontine myelinolysis usually develop in the first/ second/ third decade of life and start with symptoms such as ___.
- The symptoms of central pontine myelinolysis typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with central pontine myelinolysis may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of central pontine myelinolysis include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with central pontine myelinolysis is approximately [--]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with central pontine myelinolysis.
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of the tumor; [subtype of disease/malignancy] have the most favorable prognosis.